БУЛЛЕНС, Шерри (US),БАНТИНГ, Стюарт (US),ЧОУ, Тяньвэй (US),ОКХАМАФЕ, Аугустус, О. (US),ПРАЙС, Кристофер, П. (DE),ВЕНДТ, Дэниел, Дж. (US),ЯП, Кларенс (US)
申请号：
RU2018106890
公开号：
RU2018106890A
申请日:
2016.08.01
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
